Terug
Dagbereik
€ 0,72
€ 0,80
52-Weeksbereik
€ 0,60
€ 0,83
Volume
3.000
50D / 200D Gem.
€ 0,75
/
€ 0,76
Vorige Slotkoers
€ 0,80
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 20,9 | 0,3 |
| P/B | 1,4 | 2,9 |
| ROE % | 6,7 | 3,7 |
| Net Margin % | 9,2 | 3,8 |
| Rev Growth 5Y % | 1,4 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,04
€ 0,04 – € 0,04
|
870 M | 1 |
| FY2027 |
€ 0,03
€ 0,03 – € 0,03
|
830 M | 1 |
| FY2026 |
€ 0,03
€ 0,03 – € 0,03
|
790 M | 1 |
Belangrijkste Punten
Revenue grew 1,38% annually over 5 years — modest growth
Debt/Equity of 0,11 — conservative balance sheet
Generating 98,04M in free cash flow
Cash machine — converts 139,03% of earnings into free cash flow
Capital efficient — spends only 1,03% of revenue on capex
Groei
Revenue Growth (5Y)
1,38%
Revenue (1Y)1,75%
Earnings (1Y)13,29%
FCF Growth (3Y)-23,79%
Kwaliteit
Return on Equity
6,69%
ROIC5,84%
Net Margin9,22%
Op. Margin11,93%
Veiligheid
Debt / Equity
0,11
Current Ratio1,31
Interest Coverage22,30
Waardering
P/E Ratio
20,88
P/B Ratio1,39
EV/EBITDA13,98
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,75% | Revenue Growth (3Y) | 3,93% |
| Earnings Growth (1Y) | 13,29% | Earnings Growth (3Y) | -11,56% |
| Revenue Growth (5Y) | 1,38% | Earnings Growth (5Y) | -4,33% |
| Profitability | |||
| Revenue (TTM) | 764,73M | Net Income (TTM) | 70,52M |
| ROE | 6,69% | ROA | 4,94% |
| Gross Margin | 17,87% | Operating Margin | 11,93% |
| Net Margin | 9,22% | Free Cash Flow (TTM) | 98,04M |
| ROIC | 5,84% | FCF Growth (3Y) | -23,79% |
| Safety | |||
| Debt / Equity | 0,11 | Current Ratio | 1,31 |
| Interest Coverage | 22,30 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 20,88 | P/B Ratio | 1,39 |
| P/S Ratio | 1,93 | PEG Ratio | 1,77 |
| EV/EBITDA | 13,98 | Dividend Yield | 0,03% |
| Market Cap | 1,47B | Enterprise Value | 1,28B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 764,73M | 751,56M | 708,03M | 822,92M | 723,79M |
| Net Income | 70,52M | 62,24M | 90,15M | 143,21M | 84,17M |
| EPS (Diluted) | 0,04 | 0,03 | 0,05 | 0,08 | 0,04 |
| Gross Profit | 136,63M | 486,14M | 315,94M | 639,98M | 580,52M |
| Operating Income | 91,27M | 82,49M | 115,76M | 195,85M | 121,31M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,43B | 1,53B | 1,53B | 1,50B | 1,55B |
| Total Liabilities | 373,70M | 465,82M | 484,38M | 467,30M | 568,67M |
| Shareholders' Equity | 1,06B | 1,05B | 1,03B | 1,02B | 960,79M |
| Total Debt | 114,76M | 88,17M | 124,70M | 96,14M | 198,13M |
| Cash & Equivalents | 310,56M | 343,67M | 343,60M | 253,13M | 264,99M |
| Current Assets | 435,48M | 516,32M | 484,70M | 494,35M | 439,10M |
| Current Liabilities | 333,33M | 381,94M | 379,38M | 362,99M | 416,61M |